Novo Nordisk shares drop as much as 7% despite $23 billion obesity drug sales target
The decline came even as the Danish drugmaker set an ambitious sales goal for its weight-loss treatments, CNBC reported.
Shares of Novo Nordisk fell as much as 7% even after the company set a $23 billion sales target for its blockbuster obesity drugs, according to CNBC.
CNBC did not report a specific reason investors gave for the decline, noting only that the drop came despite the ambitious sales goal set by the Danish pharmaceutical company for its weight-loss treatments.
Sources
- Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Stocks making the largest moves midday: Carnival, Fair Isaac, Bloom Energy, Iovance Biotherapeutics & more
A report from CNBC — Top News sets out the main available details, with claims kept attributed to their sources.
Report: European stocks close mixed as bond yields rise, euro weakens
A report from Anadolu Agency (Turkey) sets out the main available details, with claims kept attributed to their sources.
Report: Stocks are little changed as traders watch Treasury yield moves: Live updates
A report from CNBC — Top News sets out the main available details, with claims kept attributed to their sources.
Saudi Arabia Resumes Oil Loading at Yanbu Port After East-West Pipeline Restart
Shipping data and satellite imagery reveal resumption of loading operations following pipeline shutdown caused by earlier attacks.
OpenAI Reportedly in Talks to Raise $30 Billion at $1.4 Trillion Valuation
OpenAI is said to be negotiating a new funding round that would value the company at $1.4 trillion, reportedly its last before a delayed 2027 public listing.
Ford CEO Jim Farley: Europe Is Too Late to Counter Chinese Automakers, but the U.S. Still Has Time
Farley said Chinese electric-vehicle makers have already outpaced European rivals, but argued the United States can still respond before losing the same ground.